Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Day One Reports Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib in Relapsed Pediatric Glioma
Day One Biopharmaceuticals (NASDAQ: DAWN) has announced positive initial data for the first 22 Response Assessment for Neuro-Oncology evaluable patients enrolled in the on going phase 2 FIREFLY-1 clinical...